MedTrace Logo

Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid

NCT00431119 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2007-02-05

No results posted yet for this study

Summary

To investigate the safety and efficacy of oral methylprednisolone combined with azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.

Conditions

  • Bullous Pemphigoid

Interventions

DRUG

Azathioprine or Mycophenolate mofetil

Sponsors & Collaborators

Principal Investigators

  • Stefan Beissert, MD · Dermatology, Univ. of Muenster, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-10-31
Completion
2000-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00431119 on ClinicalTrials.gov